Long-term prognosis after deep venous thrombosis

Current Opinion in Hematology

Volumn 15, Issue 5, 2008, Pages 494-498

  Shbaklo, Hadia ^a   Kahna, Susan R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Deep vein thrombosis; Postthrombotic syndrome; Quality of life; Risk factors

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; D DIMER; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULATION; ASSISTIVE TECHNOLOGY DEVICE; BLOOD CLOT LYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPRESSION GARMENT; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; EXERCISE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INCIDENCE; LONG TERM CARE; OBESITY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT DURATION; VEIN BLOOD FLOW; VEIN VALVE; VEIN THROMBOSIS;

HUMANS; POSTTHROMBOTIC SYNDROME; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; STOCKINGS, COMPRESSION; VENOUS THROMBOSIS;

EID: 55249116816     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32830abde2     Document Type: Review

References (49)

1. Kahn SR. The postthrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134:357-365.
2. Kahn S, Ducruet T, Arsenault L, et al. Predictors of the development of postthrombotic syndrome after acute symptomatic deep vein thrombosis: two-year results from a Canadian multicenter prospective cohort study (The VETO Study) [abstract]. In: 47th Annual Meeting of the American Society of Hematology; 3-6 December 2005; New Orleans, Louisiana, USA.
3. Schulman S, Lindmarker P, Holmstrom M, et al. Postthrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4:734-742.
4. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Int Med 2004; 164:17-26.
5. Prandoni P, Lensing A, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7.
6. Prandoni P, Lensing AWA, Prins MH, et al. Below-knee elastic compression stockings to prevent the postthrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141:249-256.
7. Stain M, Schonauer V, Minar E, et al. The postthrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3:2671-2676.
8. Van Dongen CJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3:939-942.
9. Piovella F, Crippa L, Barone M, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002; 87:515-522.
10. Prandoni P, Lensing AWA, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137:955-960.
11. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 2005; 94:362-365.
12. Marchena Yglesias PJ, Nieto Rodriguez JA, Serrano MS, et al. Acute reactives and markers of inflammation in venous thromboembolic disease: clinical and evolution outcomes. An Med Interna 2006; 23:105-110.
13. Prandoni P, Frulla M, Sartor D, et al. Venous abnormalities and the post-thrombotic syndrome. J Thromb Haemost 2005; 3:401-402.
14. Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28:826-833.
15. Monreal M, Martorell A, Callejas J, et al. Venographic assessment of deep vein thrombosis and risk of developing postthrombotic syndrome: a prospective study. J Intern Med 1993; 233:233-238.
16. Strandness D, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289-1292.
17. Schulman S, Granqvist S, Juhlin-Dannfelt A, Lockner D. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand 1986; 219:349-357.
18. McLafferty RB, MonetaGL, Passman MA, et al. Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. J Vasc Surg 1998; 27:50-56.
19. Young L, Ockelford P, Milne D, et al. Posttreatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost 2006; 4:1919-1924.
20. Kahn SR, Kearon C, Julian JA, et al. Predictors of the postthrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005; 3:718-723.
21. Killewich LA, Martin R, Cramer M, et al. An objective assessment of the physiologic changes in the postthrombotic syndrome. Arch Surg 1985; 120:424-426.
22. Yamaki T, Nozaki M, Sakurai H, et al. High peak reflux velocity in the proximal deep veins is a strong predictor of advanced postthrombotic sequelae. J Thromb Haemost 2007; 5:305-312.
23. Kahn S, Shbaklo H, Shapiro S, et al. Effectiveness of compression stockings to prevent the postthrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord 2007; 7:21.
24. Villalta S, Bagatella P, Piccioli A, et al. Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome [abstract]. Haemostasis 1994; 24:158a.
25. Porter JM, Moneta GL, An International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg 1995; 21:635-645.
26. Ginsberg JS, Gent M, Turkstra F, et al. Postthrombotic syndrome after hip or knee arthroplasty. Arch Intern Med 2000; 160:669-672.
27. Ginsberg JS, Magier D, MacKinnon B, et al. Intermittent compression units for severe postphlebitic syndrome: a randomized crossover study. CMAJ 1999; 160:1303-1306.
28. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2001:CD000265.
29. O'Donnell MJ, McRae S, Kahn SR, et al. Evaluation of a venous-return assist device to treat severe postthrombotic syndrome (VENOPTS): a randomized controlled trial. Thromb Haemost 2008; 99:623-629.
30. Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 2007 [Epub ahead of print].
31. Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev 2006: CD001367.
32. Baglin T. Unprovoked deep vein thrombosis should be treated with long-term anticoagulation: no. J Thromb Haemost 2007; 5:2336-2339.
33. Kearon C. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes. J Thromb Haemost 2007; 5:2330-2335.
34. Ng CM, Rivera JO. Meta-analysis of streptokinase and heparin in deep vein thrombosis. Am J Health Syst Pharm 1998; 55:1995-2001.
35. Goldhaber S, Buring J, Lipnick R, Hennekens C. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76:393-397.
36. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:401 S-428S.
37. Wells P, Forster AJ. Thrombolysis in deep vein thrombosis: is there still an indication? Thromb Haemost 2001; 86:499-508.
38. ArpaiaG,CimminielloC, MastrogiacomoO,deGaudenzi E. Efficacy of elastic compression stockings used early or after resolution of the edema on recanalization after deep venous thrombosis: the COM.PRE Trial. Blood Coagul Fibrinolysis 2007; 18:131-137.
39. Giannoukas AD, Labropoulos N, Michaels JA. Compression with or without early ambulation in the prevention of postthrombotic syndrome: a systematic review. Eur J Vasc Endovasc Surg 2006; 32:217-221.
40. Kakkos SK, Daskalopoulou SS, Daskalopoulos ME, et al. Review on the value of graduated elastic compression stockings after deep vein thrombosis. Thromb Haemost 2006; 96:441-445.
41. Kolbach D, Sandbrink M, Neumann H, Prins M. Compression therapy for treating stage I and II (Widmer) postthrombotic syndrome. Cochrane Database Syst Rev 2003:CD004177.
42. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162:1144-1148.
43. Kahn SR, M'Lan CE, Lamping DL, et al. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost 2004; 2:2146-2151.
44. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the two years following deep venous thrombosis. J Thromb Haemost (in press).
45. Heit JA, Rooke TW, Silverstein MD, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg 2001; 33:1022-1027.
46. Harrison M, Graham I, Friedberg E, et al. Assessing the population with leg and foot ulcers. Can Nurse 2001; 97:18-23.
47. Caprini JA, Botteman MF, Stephens JM, et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003; 6:59-74.
48. MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and postthrombotic syndrome. Am J Health Syst Pharm 2006; 63:S5-S15.
49. Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994; 31:49-53.